According to a JDRF press release, a consortium of academic and industrial partners has announced a collaboration called AP@home that aims to develop an artificial pancreas which would allow automated glucose control for people with insulin treated diabetes.
In the first phase of the AP@home project, currently available AP algorithms will be tested with CGM (continuous glucose monitoring) systems and insulin pumps already on the market, using a “two-port” approach that requires two skin punctures to attach the glucose monitor and the insulin pump. In this stage, the aim will be to improve the accuracy of the glucose sensors and the safety and effectiveness of the algorithms that relate insulin delivery to blood glucose levels.
In parallel, innovative AP systems will be developed that combine an insulin pump and a CGM system into a single device that uses only one access point through the skin. The project is expected to take four years.
